Ghazi Kashmolah - Feb 16, 2023 Form 4 Insider Report for Lucira Health, Inc. (LHDXQ)

Role
Ex VP & Chief Quality Officer
Signature
/s/ Richard Narido, Attorney-in-Fact for Ghazi Kashmolah
Stock symbol
LHDXQ
Transactions as of
Feb 16, 2023
Transactions value $
-$1,358
Form type
4
Date filed
2/21/2023, 11:38 AM
Previous filing
Dec 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LHDXQ Common Stock Sale -$1.36K -5.03K -3.61% $0.27* 134K Feb 16, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ghazi Kashmolah is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units granted on September 30,2021 for 197,240 shares.